Abiopharma

🔍 Hippel James (Executive)

Company: BIO-TECHNE Corp (TECH)

Report Date: 2026-08-15

Detailed Transactions and Holdings:

• Acquired 9,779 shares of Common Stock (Direct)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 174,493.00 | transaction_form_type: 4
• Sold 4,310 shares of Common Stock at $72.4 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 170,183.00 | transaction_form_type: 4
• Sold 866 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 12,999.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Sold 12,999 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-08-15 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Sold 34,982 shares of Performance Stock Options (Right to Buy) at $84.61 per share (Derivative)
  Date: 2026-08-15 | Code: D | Expires: 2030-08-15 | equity_swap_involved: 0 | shares_owned_after: 2,332.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 4,010 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,011.00 | transaction_form_type: 4 | Footnotes: F2, F7, F7
• Sold 4,903 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,807.00 | transaction_form_type: 4 | Footnotes: F2, F11, F11
• Holds 167,328 shares of Stock Options (Right to Buy) at $66.97 per share (Derivative)
  Date: 2026-08-15 | Code: H | Expires: 2027-08-05 | shares_owned_after: 167,328.00 | Footnotes: F1
• Holds 40,536 shares of Stock Options (Right to Buy) at $120.46 per share (Derivative)
  Date: 2026-08-15 | Code: H | Expires: 2028-08-06 | shares_owned_after: 40,536.00 | Footnotes: F1
• Holds 45,220 shares of Stock Options (Right to Buy) at $94.52 per share (Derivative)
  Date: 2026-08-15 | Code: H | Expires: 2029-08-15 | shares_owned_after: 45,220.00 | Footnotes: F1
• Holds 45,923 shares of Stock Options (Right to Buy) at $84.61 per share (Derivative)
  Date: 2026-08-15 | Code: H | Expires: 2030-08-15 | shares_owned_after: 45,923.00 | Footnotes: F5
• Holds 24,062 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-08-15 | Code: H | shares_owned_after: 24,062.00 | Footnotes: F2, F6, F6
• Holds 32,417 shares of Stock Options (Right to Buy) at $74.91 per share (Derivative)
  Date: 2026-08-15 | Code: H | Expires: 2034-08-15 | shares_owned_after: 32,417.00 | Footnotes: F8
• Holds 23,089 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-15 | Code: H | shares_owned_after: 23,089.00 | Footnotes: F2, F9, F9
• Holds 29,420 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-08-15 | Code: H | shares_owned_after: 29,420.00 | Footnotes: F2, F10, F10
• Holds 37,632 shares of Stock Options (Right to Buy) at $53.6 per share (Derivative)
  Date: 2026-08-15 | Code: H | Expires: 2035-08-15 | shares_owned_after: 37,632.00 | Footnotes: F12

Footnotes:

• F1: Fully exercisable.
• F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
• F3: On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited.
• F4: On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited.
• F5: Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
• F6: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
• F7: 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027.
• F8: Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.
• F9: 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.
• F10: Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
• F11: 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028.
• F12: Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.